<DOC>
	<DOC>NCT00190684</DOC>
	<brief_summary>To learn about the safety and any side effects of atomoxetine when given to children and adolescents for about 5 years (long-term) and to learn whether atomoxetine can help children and adolescents with attention-deficit/hyperactivity disorder (ADHD) who take the drug for about 5 years (long-term). Study participants can be atomoxetine naive, atomoxetine experienced whose therapy has been interrupted or, atomoxetine experienced on a known stable dose.</brief_summary>
	<brief_title>Long-Term, Open Label Atomoxetine Study</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Must be at least 6 years old but less than 18 years old when enrolled in first atomoxetine study Must meet the study criteria for ADHD Must be willing to have blood drawn and to complete other test required for this study allergic to more than 1 kind of medicine or have had multiple bad reactions to any drug taking certain medicines that could interact with atomoxetine plan to move too far away from a doctor participating in this study in the next 5 years current or past history of any of the following: alcohol or drug abuse within the past 3 months, bipolar I or II disorder, high blood pressure, organic brain disease or seizures, psychosis, other disorders or conditions diagnosed by a doctor that might make you unsuitable to participate in this study</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>